Medicare AdvantageBilling CodesLow impact
MA06.006h, Lyme Disease: Diagnosis and Intravenous (IV) Antibiotic Therapy
Independence Blue Cross·Infectious Disease, Neurology, Rheumatology +2 more·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated MA06.006h to reflect CPT code changes effective 04/01/2026, specifically revising the narrative for CPT code 0580U related to Lyme disease diagnosis and IV antibiotic therapy. No changes to coverage criteria or medical necessity definitions were made; this is a technical CPT code update only.
Action Required
By April 1, 2026: Billing team must verify that billing system reflects the updated CPT code 0580U narrative and continues to properly map to Lyme disease diagnosis coding. No workflow changes are required as coverage criteria remain unchanged. Confirm that claims submission logic for serologic and PCR testing (CPT 86617, 86618, 87475, 87476) and home infusion therapy codes (S9494, S9497) remain consistent with existing policy. Monitor for any additional guidance from Independence Blue Cross regarding the 0580U code narrative revision.